Jacobs & CO Merck & Co., Inc. Transaction History

Jacobs & CO

$983 Million
Q4 2024

A detailed history of Jacobs & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jacobs & CO holds 113,641 shares of MRK stock, worth $9.96 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

113,641

Previous 108,890 4.36%

Holding current value

$9.96 Million

Previous $12.4 Million 8.57%

% of portfolio

1.15%

Previous 1.24%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 10, 2025	BUY	$96.31 - $114.76 $457,568 - $545,224	4,751 Added 4.36%	113,641 $11.3 Million
Q3 2024 Oct 01, 2024	BUY	$111.15 - $128.97 $712,138 - $826,310	6,407 Added 6.25%	108,890 $12.4 Million
Q2 2024 Jul 12, 2024	SELL	$123.8 - $132.96 $87,526 - $94,002	-707 Reduced 0.69%	102,483 $12.7 Million
Q1 2024 Apr 12, 2024	SELL	$113.24 - $131.95 $354,780 - $413,399	-3,133 Reduced 2.95%	103,190 $13.6 Million
Q4 2023 Jan 17, 2024	BUY	$100.18 - $109.02 $508,012 - $552,840	5,071 Added 5.01%	106,323 $11.6 Million
Q3 2023 Oct 13, 2023	BUY	$102.95 - $114.33 $133,629 - $148,400	1,298 Added 1.3%	101,252 $10.4 Million
Q2 2023 Jul 11, 2023	SELL	$108.61 - $118.38 $654,483 - $713,357	-6,026 Reduced 5.69%	99,954 $11.5 Million
Q1 2023 Apr 17, 2023	SELL	$102.94 - $114.86 $816,108 - $910,610	-7,928 Reduced 6.96%	105,980 $11.3 Million
Q4 2022 Jan 13, 2023	SELL	$87.44 - $112.11 $1.22 Million - $1.57 Million	-14,002 Reduced 10.95%	113,908 $12.6 Million
Q3 2022 Oct 11, 2022	SELL	$84.53 - $94.96 $126,625 - $142,250	-1,498 Reduced 1.16%	127,910 $11 Million
Q2 2022 Jul 19, 2022	SELL	$83.49 - $94.64 $891,756 - $1.01 Million	-10,681 Reduced 7.62%	129,408 $11.8 Million
Q1 2022 Apr 14, 2022	SELL	$73.51 - $82.4 $140,477 - $157,466	-1,911 Reduced 1.35%	140,089 $11.5 Million
Q4 2021 Jan 21, 2022	BUY	$72.28 - $90.54 $319,766 - $400,548	4,424 Added 3.22%	142,000 $10.9 Million
Q3 2021 Oct 13, 2021	BUY	$71.68 - $78.83 $623,759 - $685,978	8,702 Added 6.75%	137,576 $10.3 Million
Q2 2021 Jul 15, 2021	BUY	$70.31 - $77.77 $1.1 Million - $1.21 Million	15,617 Added 13.79%	128,874 $10 Million
Q1 2021 Apr 05, 2021	BUY	$68.86 - $81.11 $702,647 - $827,646	10,204 Added 9.9%	113,257 $8.73 Million
Q4 2020 Jan 12, 2021	BUY	$71.77 - $79.65 $740,522 - $821,828	10,318 Added 11.13%	103,053 $8.43 Million
Q3 2020 Dec 03, 2020	BUY	$73.18 - $82.95 $389,317 - $441,294	5,320 Added 6.09%	92,735 $7.69 Million
Q2 2020 Jul 09, 2020	BUY	$70.42 - $80.13 $639,695 - $727,900	9,084 Added 11.6%	87,415 $6.76 Million
Q1 2020 Apr 13, 2020	BUY	$63.36 - $87.82 $59,685 - $82,726	942 Added 1.22%	78,331 $6.03 Million
Q4 2019 Jan 29, 2020	BUY	$77.58 - $87.54 $514,200 - $580,215	6,628 Added 9.37%	77,389 $7.04 Million
Q3 2019 Nov 04, 2019	BUY	$76.08 - $82.93 $49,832 - $54,319	655 Added 0.93%	70,761 $5.96 Million
Q2 2019 Aug 01, 2019	BUY	$69.84 - $81.59 $1.8 Million - $2.1 Million	25,709 Added 57.91%	70,106 $5.88 Million
Q1 2019 Apr 29, 2019	BUY	$69.58 - $79.36 $3.09 Million - $3.52 Million	44,397 New	44,397 $3.69 Million

Others Institutions Holding MRK

# of Institutions

3,953

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $222B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account